# Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

> **NCT04087720** · PHASE4 · COMPLETED · sponsor: **Amgen** · enrollment: 20 (actual)

## Conditions studied

- Uncontrolled Gout
- Kidney Transplant

## Interventions

- **BIOLOGICAL:** Pegloticase

## Key facts

- **NCT ID:** NCT04087720
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-09
- **Primary completion:** 2021-07-06
- **Final completion:** 2021-09-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04087720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04087720, "Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04087720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*